CLENE NANOMEDICINE, INC.

Profile

Company Names

CLENE NANOMEDICINE, INC.

Addresses

6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT 84121

Phone Numbers

801-676-9695

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$48,665,562.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-08-10 
$42,540,574.00 
$46,189,425.00 
$3,648,851.00 
Equity 
1
2020-02-07 
$6,124,988.00 
$7,000,000.00 
$875,012.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROB 
 
ETHERINGTON 
EXECUTIVE OFFICER, DIRECTOR
CLENE NANOMEDICINE, INC.
ROBERT 
 
GAY 
DIRECTOR
MERRIMACK PHARMACEUTICALS INC   |  CLENE NANOMEDICINE, INC.
SHALOM 
 
JACOBOVITZ 
DIRECTOR
CIVI BIOPHARMA HOLDINGS, INC.   |  CLENE NANOMEDICINE, INC.   |  CLENE INC.
DAVID 
 
LISONBEE 
DIRECTOR
CLENE NANOMEDICINE, INC.
RYAN 
 
LUND 
DIRECTOR
CEREBRI AI INC.   |  CLENE NANOMEDICINE, INC.
ALISON 
 
MOSCA 
DIRECTOR
CLENE NANOMEDICINE, INC.   |  CLENE INC.
JOHN 
 
STEVENS 
DIRECTOR
CARDIOVASCULAR SIMULATION, INC.   |  HEARTFLOW, INC.   |  ENTREC TRANSPORTATION SERVICES LTD.   |  WHEELS GROUP INC.   |  ENTREC CORP   |  APNICURE, INC.   |  MAKO MINING CORP.   |  CLENE NANOMEDICINE, INC.   |  CLENE INC.   |  ALTERNATIVE SUSTAINABILITY LLC
REED 
 
WILCOX 
DIRECTOR
CLENE NANOMEDICINE, INC.   |  CLENE INC.
CHAD 
 
YOUNG 
DIRECTOR
CLENE NANOMEDICINE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-08-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-10 
2020-07-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CREWE CAPITAL, LLC
152527